Literature Collection

921

North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic

Type: Journal Article

Authors: P. M. Hughes, C. W. Easterly, K. C. Thomas, C. M. Shea, M. E. Domino

Year: 2024

Topic(s):

, , , ,

Reference Links:

Export Citation: RIS

View details

922

Not Just Squeezing the Balloon: A Comprehensive Set of State Strategies for Addressing Health Care Cost

Type: Government Report

Authors: Elliott S. Fisher, Christopher F. Koller, Carrie H. Cola, Alena Berube

Year: 2024

Publication Place: New York, NY

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

923

Novel approach to integrating mental health care into a primary care setting: Development, implementation, and outcomes

Type: Journal Article

Authors: Jenifer L. Vohs, Molin Shi, Emily G. Holmes, Melissa Butler, Sarah A. Landsberger, Sujuan Gao, Fanqian Ouyang, Evgenia Teal, Kristen Merkitch, William Kronenberger

Year: 2022

Topic(s):

Reference Links:

Export Citation: RIS

View details

924

NP Safe Prescribing Of Controlled Substances While Avoiding Drug Diversion

Type: Report

Authors: A. M. Dydyk, D. C. Sizemore, L. M. Haddad, L. Lindsay, B. R. Porter

Year: 2022

Publication Place: Treasure Island (FL)

Topic(s):

, , , ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links:

Access Resource

Export Citation: RIS

View details

925

Obsessive-compulsive disorder in the primary care setting

Type: Book Chapter

Authors: David C. Rettew, Tanya K. Murphy

Year: 2007

Publication Place: Mahwah, NJ, US

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Export Citation: RIS

View details

926

Off the Hamster Wheel? Qualitative Evaluation of a Payment-Linked Patient-Centered Medical Home (PCMH) Pilot

Type: Journal Article

Authors: Asaf Bitton, Gregory R. Schwartz, Elizabeth E. Stewart, Daniel E. Henderson, Carol A. Keohane, David W. Bates, Gordon D. Schiff

Year: 2012

Publication Place: United States

Topic(s):

,

Export Citation: RIS

View details

927

Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis

Type: Journal Article

Authors: J. B. King, A. M. Sainski-Nguyen, B. K. Bellows

Year: 2016

Publication Place: England

Abstract: The objective of this analysis was to compare the cost-effectiveness of clinic-based methadone maintenance therapy (MMT) and office-based buprenorphine maintenance therapy (BMT) from the perspective of third-party payers in the United States. The authors used a Markov cost-effectiveness model. A hypothetical cohort of 1000 adult, opioid-dependent patients was modeled over a 1-year time horizon. Patients were allowed to transition between the health states of in opioid dependence treatment and either abusing or not abusing opioids, or to have dropped out of treatment. Probabilities were derived from randomized clinical trials comparing methadone and buprenorphine. Costs included drug and administration, clinic visits, and therapy sessions. Effectiveness outcomes examined were (1) retention in the treatment program and (2) opioid abuse-free weeks. For retention in treatment at 1 year, MMT was more costly ($4,613 vs. $4,155) and more effective (20.3% vs. 15.9%) than BMT, resulting in an incremental cost-effectiveness ratio (ICER) of $10,437 per additional patient retained in treatment. MMT was also more effective than BMT in terms of opioid abuse-free weeks (9.2 vs. 9.1 weeks), resulting in an ICER of $8,515 per opioid abuse-free week gained. One-way sensitivity analyses found costs per week of MMT to have the largest impact on the retention-in-treatment outcome, whereas the probability of dropping out with MMT had the greatest impact on opioid abuse-free weeks. The authors conclude that MMT is cost-effective compared with BMT for the treatment of patients with opioid dependence. However, the treatment of substance abuse is complex, and decision makers should also consider individual patient characteristics when making coverage decisions.

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

928

Old tech but not low tech: telephone-based treatment provision for substance use

Type: Journal Article

Authors: M. R. Walton, A. W. Kang, C. DelaCuesta, A. Hoadley, R. Martin

Year: 2024

Topic(s):

, , ,

Reference Links:

Export Citation: RIS

View details

929

One size fits some: The impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention

Type: Journal Article

Authors: J. M. Pyne, K. M. Rost, F. Farahati, S. P. Tripathi, J. Smith, D. K. Williams, J. Fortney, J. C. Coyne

Year: 2005

Publication Place: England

Abstract: BACKGROUND: Despite their impact on outcomes, the effect of patient treatment attitudes on the cost-effectiveness of health-care interventions is not widely studied. This study estimated the impact of patient receptivity to antidepressant medication on the cost-effectiveness of an evidence-based primary-care depression intervention. METHOD: Twelve community primary-care practices were stratified and then randomized to enhanced (intervention) or usual care. Subjects included 211 patients beginning a new treatment episode for major depression. At baseline, 111 (52.6%) and 145 (68.7%) reported receptivity to antidepressant medication and counseling respectively. The intervention trained the primary-care teams to assess, educate, and monitor depressed patients. Twelve-month incremental (enhanced minus usual care) total costs and quality-adjusted life years (QALYs) were calculated. RESULTS: Among patients receptive to antidepressants, the mean incremental cost-effectiveness ratio was dollar 5,864 per QALY (sensitivity analyses up to dollar 14,689 per QALY). For patients not receptive to antidepressants, the mean incremental QALY score was negative (for both main and sensitivity analyses), or the intervention was at least no more effective than usual care. CONCLUSIONS: These findings suggest a re-thinking of the 'one size fits all' depression intervention, given that half of depressed primary-care patients may be non-receptive to antidepressant medication treatment. A brief assessment of treatment receptivity should occur early in the treatment process to identify patients most likely to benefit from primary-care quality improvement efforts for depression treatment. Patient treatment preferences are also important for the development, design, and analysis of depression interventions.

Topic(s):

Reference Links:

Export Citation: RIS

View details

930

Operational Lessons from a Large Accountable Care Organization

Type: Journal Article

Authors: Sreekanth K. Chaguturu, Margaret Costello, David Connolly, Gary L. Gottlcib, Timothy G. Ferris

Year: 2014

Topic(s):

Export Citation: RIS

View details

931

Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada

Type: Journal Article

Authors: Megan Kurz, Laura M. Dale, Jeong Eun Min, Natt Hongdilokkul, Leigh Greiner, Maureen Olley, Katherine E. McLeod, Amanda Slaunwhite, Bohdan Nosyk

Year: 2022

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

932

Opioid and CNS-depressant medication prescribing among older adults enrolled in Medicare Advantage versus fee-for-service Medicare

Type: Journal Article

Authors: Lianlian Lei, Julie P. W. Bynum, Donovan T. Maust

Year: 2021

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

933

Opioid Prescribing for Chronic Pain in Federally Qualified Health Centers Post–Centers for Disease Control and Prevention Guidelines

Type: Journal Article

Authors: Kerry A. Milner, Susan M. DeNisco, Anna E. Greer

Year: 2021

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

934

Opioid Settlements, Big Pharma, and Racial Disparities in the Opioid Epidemic

Type: Report

Authors: Jerel Ezell, Sugy Choi

Year: 2025

Publication Place: New York, NY

Topic(s):

, , , ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

935

Opioid substitution: Improving cost-efficiency

Type: Journal Article

Authors: S. Sullivan

Year: 2013

Publication Place: Switzerland

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

936

Opioid Use Disorder Among the Economically Disadvantaged in the Rural South

Type: Journal Article

Authors: D. L. Albright, Z. Suntai, J. T. McDaniel, K. Johnson, H. Henson, E. Robertson, S. McIntosh

Year: 2023

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

937

Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers

Type: Journal Article

Authors: A. Mahone, M. Enich, P. Treitler, J. Lloyd, S. Crystal

Year: 2023

Abstract:

Background: In the US, seventy percent of drug-related deaths are attributed to opioids. In response to the ongoing opioid crisis, New Jersey's (NJ) Medicaid program implemented the MATrx model to increase treatment access for Medicaid participants with opioid use disorder (OUD). The model's goals include increasing the number of office-based treatment providers, enhancing Medicaid reimbursement for certain treatment services, and elimination of prior authorizations for OUD medications.Objectives: To explore office-based addiction treatment providers' experiences delivering care in the context of statewide policy changes and their perspectives on treatment access changes and remaining barriers.Methods: This qualitative study used purposive sampling to recruit office-based New Jersey medications for opioid use disorder (MOUD) providers . Twenty-two providers (11 females, 11 males) discussed treatment experiences since the policy changes in 2019, including evaluations of the current state of OUD care in New Jersey and perceived outcomes of the MATrx model policy changes.Results: Providers reported the MOUD climate in NJ improved as Medicaid implemented policies intended to reduce barriers to care and increase treatment access. Elimination of prior authorizations was noted as important, as it reduced provider burden and allowed greater focus on care delivery. However, barriers remained, including stigma, pharmacy supply issues, and difficulty obtaining injectable or non-generic medication formulations.Conclusion: NJ policies may have improved access to care for Medicaid beneficiaries by reducing barriers to care and supporting providers in prescribing MOUD. Yet, stigma and lack of psychosocial supports still need to be addressed to further improve access and care quality.

Topic(s):

, , ,

Reference Links:

Export Citation: RIS

View details

938

Opioid use disorder: Calling pharmacists to action for better preconception and pregnancy care

Type: Journal Article

Authors: Julia D. Muzzy Williamson, Natalie DiPietro Mager, David Bright, Justin W. Cole

Year: 2022

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

939

Opportunities and Challenges to Utilizing Telehealth Technologies in the Provision of Medication Assisted Therapies in the Medi-Cal program

Type: Report

Authors: Center for Connected Health Policy

Year: 2018

Topic(s):

, , , , ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (1300 KB)

Reference Links: PDF (1300 KB)

Export Citation: RIS

View details

940

Opportunities to Promote Medications for Opioid Use Disorder in Federally Qualified Health Centers

Type: Government Report

Authors: Meryl Schulman, Ashley Jasko

Year: 2024

Publication Place: Hamilton, NJ

Topic(s):

, , , ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (559 KB)

Reference Links: PDF (559 KB)

Export Citation: RIS

View details